Abstract
Cancer cells leaving the primary tumor immunosuppressive microenvironment become vulnerable to active immune surveillance and require mechanisms of immunoevasion to survive in the circulation. Studies have identified several pathways by which circulating tumor cells (CTCs) might escape the immune system/immunotherapy attack. The PD-1/PD-L1 axis is an immune checkpoint regulator, playing a major role in maintaining self-tolerance. It is now well recognized that tumor cells co-opt the PD-1/PD-L1 axis of immune regulation to interfere with cytotoxic T lymphocyte function. Transcriptional changes in CTCs, leading to the upregulation of PD-L1, might enable them to survive in circulation. Very recent data revealed a previously unappreciated role of epithelial-mesenchymal transition (EMT) in reprogramming the immune response in the local tumor microenvironment and a mutual regulation between EMT and immunoevasion is becoming apparent. In this chapter, we will describe in detail both EpCAM-dependent and -independent approaches that allow the identification of PD-L1 expression and EMT-like features in circulating tumor cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Patel SP, Kurzrock R (2015) PD-L1 expression as a predictive biomarker in cancer immunotherapy. Mol Cancer Ther 14:847–856
Remon J, Chaput N, Planchard D (2016) Predictive biomarkers for programmed death-1/programmed death ligand immune checkpoint inhibitors in nonsmall cell lung cancer. Curr Opin Oncol 28:122–129
Buder A, Tomuta C, Filipits M (2016) The potential of liquid biopsies. Curr Opin Oncol 28:130–134
Mazel M, Jacot W, Pantel K et al (2015) Frequent expression of PD-L1 on circulating breast cancer cells. Mol Oncol 9:1773–1782
Nicolazzo C, Raimondi C, Mancini M et al (2016) Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab. Sci Rep 6:31726
Terry S, Savagner P, Ortiz-Cuaran S et al (2017) New insights into the role of EMT in tumor immune escape. Mol Oncol 11:824–846
Raimondi C, Carpino G, Nicolazzo C et al (2017) PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: a molecular shield to evade immune system? OncoImmunology 6(12):e1315488. https://doi.org/10.1080/2162402X.2017.1315488
Paoletti C, Li Y, Muñiz MC et al (2015) Significance of circulating tumor cells in metastatic triple-negative breast cancer patients within a randomized, phase II trial: TBCRC 019. Clin Cancer Res 21:2771–2779
Carpino G, Cardinale V, Renzi A et al (2015) Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis. J Hepatol 63:1220–1228
Coumans F, Terstappen L (2015) Detection and characterization of circulating tumor cells by the cellsearch approach. Methods Mol Biol 1347:263–278
Woititz CA (2008) Guideline for the use and optimization of user-defined markers. CellSearch®. https://www.cellsearchruo.com/sites/default/files/Guideline-for-Use-and-Optimization-of-User-Defined-Markers.pdf
Nicolazzo C, Raimondi C, Francescangeli F et al (2017) EpCAM-expressing circulating tumor cells in colorectal cancer. Int J Biol Markers 32(4):e415–e420. https://doi.org/10.5301/ijbm.5000284
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Nicolazzo, C., Gradilone, A., Carpino, G., Gazzaniga, P., Raimondi, C. (2019). Molecular Characterization of Circulating Tumor Cells to Study Cancer Immunoevasion. In: López-Soto, A., Folgueras, A. (eds) Cancer Immunosurveillance. Methods in Molecular Biology, vol 1884. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8885-3_17
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8885-3_17
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8884-6
Online ISBN: 978-1-4939-8885-3
eBook Packages: Springer Protocols